References
- Degos B. L., Castaigne S., Tilly H., Sigaua Daniel M. Treatment of leukemia with low-dose ARa-C: a study of 160 cases. Sent Onc 1985; 12: 196–199
- Rudnick S. A., Cadman E. C., Capizzi R. L. High dose Cytosine Arabinoside (HDARAC) in refractory acute leukemia. Cancer 1979; 44: 1189–1193
- Ettinger L. S., Biener R., Finklestein J. Z. Sequential high-dose Cytosine Arabinoside and L-Aspara ginase in childhood leukemia in relapse. Sent Onc 1985; 12: 155–159
- Hines J. D., Oken M. M., Mazza J., Keller A., Glick J. High-dose Cytosine Arabinoside and M-AMSA in refractory acute non-lymphocitic leukemia. Blood 1981; 58: 142a
- Cappizi R. L., Poole M., Cooper M. R. Treatment of poor risk acute leukemia with sequential high-dose Ara-C and Asparaginase. Blood 1984; 63: 694–700
- Messner H. A., Curtis J. E., Minder M. M. The combiner use of Cytosine Arabinoside, Cyclophosphamide and total body irradiation as preparative regimen for bone marrow transplantation in patients with AML and CML. Sem Onc 1985; 12: 287–290
- Pizzuto J., Aviles A., Ramos E., Cervera J., Aguirre J. Cytosine Arabinoside induced liver damage :histopatho logical demonstration. Med Fed One 1983; 11: 287–290
- George C. B., Mansour R. P., Redmond G., III, Gandara D. R. Hepatic dysfunction and jaundice following high-dost Cytosine Arabinoside. Cancer 1984; 54: 2360–2362
- Locasciulli A., Mieli Vergani G., Uderzo C. Chronic liver disease in children with leukemia in long-term remission. Cancer 1983; 52: 1080–1087
- Locasciulli A., Alberti A., Rossetti F. Acute and chronic hepatitis in childhood leukemia: a multicentric study from the Pediatric Cooperative Group for therapy of acute leukemia (AIL-AIEOP). Med Ped. Onc 1985; 13: 203–206
- Locasciulli A., Alberti A., Barbieri R. Evidence of nonA, nonB hepatitis in children with leukemia and chronic liver disease. Am J Dis Child 1983; 137: 354–356
- Vergani D., Locasciulli A., Masera G. Histological evidence of hepatitis B virus infection with negative serology in children with leukemia who developed chronic liver disease. Lancet 1982; i: 361–364
- Locasciulli A., Santamaria M., Masera G. Hepatitis B virus markers in children with acute leukemia: the effect of chemotherapy. J Med Virol 1985; 15: 29–33
- Wands J. R., Churia C. H., Roll F. J., Maddrey W. C. Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology 1975; 68: 105–112
- Bennett J. H., Catovsky D., Daniel U. Proposal for classification of the acute leukemias. Br J. Haematol 1976; 33: 451–458
- McDonald G. B., Tirumali N. Intestinal and liver toxicity of antineoplastic drugs. West J Med 1984; 2: 250–259
- Katz M. E., Cassileth P. A. Hyperbilirubinemia during induction therapy of acute leukemia. Cancer 1977; 40: 1390–1392